The China Mail - US panel weighs authorizing Covid vaccines for youngest children

USD -
AED 3.67315
AFN 63.498148
ALL 82.695715
AMD 376.960349
ANG 1.790083
AOA 917.000195
ARS 1386.456033
AUD 1.446508
AWG 1.8
AZN 1.681281
BAM 1.699144
BBD 2.014422
BDT 122.722731
BGN 1.709309
BHD 0.377599
BIF 2966
BMD 1
BND 1.288204
BOB 6.911051
BRL 5.154697
BSD 1.00013
BTN 93.154671
BWP 13.721325
BYN 2.963529
BYR 19600
BZD 2.011459
CAD 1.392105
CDF 2294.999741
CHF 0.798065
CLF 0.023204
CLP 915.560238
CNY 6.871978
CNH 6.89061
COP 3666.29
CRC 465.397112
CUC 1
CUP 26.5
CVE 95.501015
CZK 21.22275
DJF 178.082787
DKK 6.468595
DOP 60.493437
DZD 132.987011
EGP 54.322801
ERN 15
ETB 156.999751
EUR 0.86563
FJD 2.257499
FKP 0.750158
GBP 0.754935
GEL 2.690296
GGP 0.750158
GHS 11.000021
GIP 0.750158
GMD 73.9998
GNF 8780.000278
GTQ 7.651242
GYD 209.312427
HKD 7.836915
HNL 26.620137
HRK 6.524101
HTG 131.271448
HUF 332.436496
IDR 16977
ILS 3.125465
IMP 0.750158
INR 92.901103
IQD 1310
IRR 1318875.000276
ISK 125.009743
JEP 0.750158
JMD 157.682116
JOD 0.709014
JPY 159.282004
KES 130.089763
KGS 87.448803
KHR 4010.498058
KMF 424.499211
KPW 899.994443
KRW 1509.849549
KWD 0.30927
KYD 0.833496
KZT 473.939125
LAK 21954.999732
LBP 89549.999791
LKR 315.52795
LRD 183.850341
LSL 16.82014
LTL 2.95274
LVL 0.60489
LYD 6.374973
MAD 9.325021
MDL 17.597769
MGA 4175.000158
MKD 53.353705
MMK 2099.621061
MNT 3572.314592
MOP 8.074419
MRU 40.130023
MUR 46.809536
MVR 15.450091
MWK 1736.999933
MXN 17.849665
MYR 4.039008
MZN 63.959783
NAD 16.820084
NGN 1380.860247
NIO 36.709871
NOK 9.726703
NPR 149.047474
NZD 1.74546
OMR 0.384371
PAB 1.000126
PEN 3.459504
PGK 4.311498
PHP 60.332986
PKR 279.204736
PLN 3.70189
PYG 6469.6045
QAR 3.644502
RON 4.412899
RSD 101.609022
RUB 80.203181
RWF 1461
SAR 3.754117
SBD 8.048583
SCR 13.709478
SDG 601.00032
SEK 9.42538
SGD 1.284545
SHP 0.750259
SLE 24.598309
SLL 20969.510825
SOS 571.500048
SRD 37.350979
STD 20697.981008
STN 21.5
SVC 8.75114
SYP 110.548921
SZL 16.800677
THB 32.6085
TJS 9.585632
TMT 3.5
TND 2.91425
TOP 2.40776
TRY 44.487199
TTD 6.78508
TWD 31.916006
TZS 2600.00002
UAH 43.803484
UGX 3752.226228
UYU 40.501271
UZS 12200.000236
VES 473.325195
VND 26336
VUV 120.132513
WST 2.770875
XAF 569.874593
XAG 0.013815
XAU 0.000214
XCD 2.70255
XCG 1.80252
XDR 0.703479
XOF 564.499161
XPF 103.296241
YER 238.625044
ZAR 16.884401
ZMK 9001.196378
ZMW 19.327487
ZWL 321.999592
  • CMSC

    0.0800

    22.07

    +0.36%

  • CMSD

    0.0550

    22.205

    +0.25%

  • RBGPF

    -13.5000

    69

    -19.57%

  • GSK

    0.4800

    56.47

    +0.85%

  • BCE

    -1.2250

    24.155

    -5.07%

  • BCC

    -2.5200

    72.56

    -3.47%

  • RYCEF

    0.5500

    15.64

    +3.52%

  • AZN

    1.4800

    202.21

    +0.73%

  • RIO

    -0.7400

    94.07

    -0.79%

  • NGG

    0.9600

    87.8

    +1.09%

  • JRI

    0.0800

    12.6

    +0.63%

  • RELX

    0.3550

    33.585

    +1.06%

  • VOD

    0.0650

    15.195

    +0.43%

  • BTI

    0.6200

    58.51

    +1.06%

  • BP

    0.7550

    46.925

    +1.61%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: © AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

C.Smith--ThChM